Third-generation EGFR-TKI, for NSCLC with EGFR Ex19Del or L858R mutations, targets EGFR mutations, anti-CNS metastasis activity,
Sale!
Lucius
Replica: Osimertinib Targeted EGFR TKI for EGFRm NSCLC
Original price was: $757.00.$598.00Current price is: $598.00.
Third-generation EGFR-TKI, for NSCLC with EGFR Ex19Del or L858R mutations, targets EGFR mutations, anti-CNS metastasis activity,